Anaptysbio Stock Investor Sentiment
| ANAB Stock | USD 18.71 1.63 9.54% |
About 51% of AnaptysBio's investors are presently thinking to get in. The analysis of the overall investor sentiment regarding AnaptysBio suggests that some traders are interested. The current market sentiment, together with AnaptysBio's historical and current headlines, can help investors time the market. In addition, many technical investors use AnaptysBio stock news signals to limit their universe of possible portfolio assets.
Comfort Level 51
Impartial
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use AnaptysBio's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward AnaptysBio.
News SentimentNeutral | Hype SentimentBullish | Insider SentimentDisposing |
AnaptysBio Historical Sentiment
Although AnaptysBio's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding AnaptysBio, such as negative comments on social media and news outlets, may cause fear in the market and push AnaptysBio's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of AnaptysBio.
AnaptysBio |
AnaptysBio Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards AnaptysBio can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about AnaptysBio that are available to investors today. That information is available publicly through AnaptysBio media outlets and privately through word of mouth or via AnaptysBio internal channels. However, regardless of the origin, that massive amount of AnaptysBio data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of AnaptysBio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of AnaptysBio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to AnaptysBio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive AnaptysBio alpha.
AnaptysBio Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Acquisition by Ecor1 Capital, Llc of 65184 shares of AnaptysBio at 12.9182 subject to Rule 16b-3 | 12/30/2024 |
2 | Acquisition by Ecor1 Capital, Llc of 13268 shares of AnaptysBio at 12.9268 subject to Rule 16b-3 | 12/31/2024 |
3 | Acquisition by Ecor1 Capital, Llc of 6646 shares of AnaptysBio at 12.9506 subject to Rule 16b-3 | 01/02/2025 |
4 | Disposition of 34678 shares by Daniel Faga of AnaptysBio subject to Rule 16b-3 | 01/03/2025 |
5 | Disposition of 17850 shares by Daniel Faga of AnaptysBio subject to Rule 16b-3 | 01/06/2025 |
6 | How AnaptysBio Stock Stands Out in a Strong Industry | 01/13/2025 |
7 | Acquisition by Eric Loumeau of 7288 shares of AnaptysBio subject to Rule 16b-3 | 01/16/2025 |
8 | Acquisition by Schmid John P. of 16510 shares of AnaptysBio at 14.83 subject to Rule 16b-3 | 01/22/2025 |
9 | Disposition of 6387 shares by Daniel Faga of AnaptysBio at 15.3 subject to Rule 16b-3 | 01/24/2025 |
10 | Molina Healthcare Q4 Earnings Miss Estimates on Growing Medical Costs | 02/06/2025 |
11 | AnaptysBio, Inc. Stock Rockets 29 percent As Investors Are Less Pessimistic Than Expected | 02/14/2025 |
12 | AnaptysBio GAAP EPS of -0.72 beats by 0.91, revenue of 43.11M | 02/27/2025 |
13 | AnaptysBio, Inc. Short Interest Up 54.4 percent in February | 03/04/2025 |
14 | Acquisition by Lizzul Paul F. of 1500 shares of AnaptysBio at 18.5 subject to Rule 16b-3 | 03/18/2025 |
15 | Disposition of 5000 shares by Eric Loumeau of AnaptysBio at 14.02 subject to Rule 16b-3 | 03/19/2025 |
16 | SGS Achieves ISO 450012018 ANAB Accreditation in North America | 03/20/2025 |
17 | Disposition of 6000 shares by Eric Loumeau of AnaptysBio subject to Rule 16b-3 | 03/21/2025 |
18 | Crude Oil Gains 1 US Composite PMI Surges In March | 03/24/2025 |
Complementary Tools for AnaptysBio Stock analysis
When running AnaptysBio's price analysis, check to measure AnaptysBio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AnaptysBio is operating at the current time. Most of AnaptysBio's value examination focuses on studying past and present price action to predict the probability of AnaptysBio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AnaptysBio's price. Additionally, you may evaluate how the addition of AnaptysBio to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |